Profile data is unavailable for this security.
About the company
Carmat SAS is a France-based Company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart and which is hydraulically activated. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels and Blood Institute, Laboratoire de Recherche Biochirurgicale and others. As of December 31, 2011, a company MATRA DEFENSE held a 30.57% stake in the Company’s shareholdings.
- Revenue in EUR (TTM)895.00k
- Net income in EUR-54.36m
- Incorporated2008
- Employees177.00
- LocationCarmat SA36avenue de l'Europe, Immeuble l'EtendardVELIZY VILLACOUBLAY 78140FranceFRA
- Phone+33 139456450
- Fax+33 139456451
- Websitehttps://www.carmatsa.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mauna Kea Technologies SA | 10.90m | -2.17m | 24.02m | 67.00 | -- | -- | 22.33 | 2.20 | -0.0488 | -0.0488 | 0.2449 | -0.3386 | 0.5265 | 2.01 | 6.73 | 194,696.40 | -2.61 | -58.19 | -5.19 | -83.91 | 37.11 | -1.33 | -4.96 | -182.40 | 0.7405 | 29.85 | 2.22 | -- | -2.87 | 2.26 | 16.85 | -- | -27.66 | -- |
| Visiomed Group SA | 12.04m | -3.54m | 55.81m | 73.00 | -- | 2.44 | -- | 4.63 | -0.0119 | -0.0119 | 0.0406 | 0.0776 | 0.3453 | 1.40 | 6.88 | 174,550.70 | -10.44 | -53.01 | -12.11 | -127.09 | 91.46 | 41.03 | -30.24 | -99.08 | 1.70 | -9.31 | 0.2631 | -- | 101.38 | 6.67 | -18.40 | -- | 52.36 | -- |
| Novacyt SA | 9.14m | -29.37m | 58.26m | 222.00 | -- | 0.4674 | -- | 6.37 | -0.4159 | -0.4173 | 0.1294 | 1.76 | 0.0528 | 1.33 | 0.2622 | 41,168.79 | -16.96 | 17.69 | -20.71 | 23.82 | 43.21 | 62.82 | -321.40 | 23.87 | 4.98 | -79.02 | 0.0036 | 0.00 | -77.28 | 13.49 | -269.46 | -- | -13.46 | -- |
| Affluent Medical SAS | 0.00 | -15.02m | 62.31m | 52.00 | -- | 1.49 | -- | -- | -0.6596 | -0.6596 | 0.00 | 1.26 | 0.00 | -- | -- | 0.00 | -23.91 | -23.11 | -27.18 | -26.49 | -- | -- | -- | -- | -- | -10.51 | 0.2905 | -- | -- | -- | -2.75 | -- | -11.10 | -- |
| Carmat SA | 895.00k | -54.36m | 110.82m | 177.00 | -- | -- | -- | 123.83 | -2.25 | -2.25 | 0.0369 | -0.3817 | 0.0123 | 1.58 | 0.2029 | 5,000.00 | -74.73 | -76.92 | -89.51 | -93.77 | -3,232.74 | -- | -6,074.19 | -9,203.39 | 2.81 | -14.25 | 1.18 | -- | -84.52 | -- | 13.24 | -- | -10.97 | -- |
| Bastide Le Confort Medical SA | 523.32m | 6.32m | 112.06m | 3.55k | 20.88 | 1.38 | 1.36 | 0.2141 | 0.7299 | 0.772 | 65.57 | 11.02 | 0.7955 | 5.44 | 6.90 | 147,580.70 | 1.84 | 2.49 | 2.66 | 3.52 | 50.54 | 48.82 | 2.31 | 3.05 | 0.811 | 1.92 | 0.8391 | -- | 8.48 | 11.94 | 11.24 | 17.55 | 6.98 | -- |
| Amplitude Surgical SA | 104.05m | 43.23m | 146.94m | 416.00 | 3.40 | 1.55 | 2.68 | 1.41 | 0.9002 | 0.9002 | 2.17 | 1.97 | 0.3955 | 0.5652 | 8.83 | 244,244.10 | 16.21 | -0.3658 | 19.44 | -0.4267 | 79.41 | 78.30 | 40.98 | -1.08 | 1.21 | 0.4163 | 0.5395 | -- | 14.44 | -0.0271 | 993.58 | -- | 7.11 | -- |
| Lumibird SA | 203.56m | 7.13m | 314.54m | 1.05k | 39.34 | 1.62 | 12.85 | 1.55 | 0.3559 | 0.3559 | 9.14 | 8.62 | 0.5238 | 1.09 | 4.05 | 193,497.10 | 1.83 | 3.13 | 2.44 | 3.99 | 61.68 | 61.76 | 3.50 | 5.89 | 1.62 | 2.47 | 0.4287 | 0.00 | 6.60 | 15.12 | -37.23 | -2.47 | 18.34 | -- |
Data as of Apr 19 2024. Currency figures normalised to Carmat SA's reporting currency: Euro EUR
1.77%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| OFI Invest Asset Management SAas of 29 Feb 2024 | 220.00k | 0.76% |
| La Fran�aise Asset Management SASas of 29 Dec 2023 | 172.50k | 0.59% |
| Apo Asset Management GmbHas of 30 Sep 2023 | 66.00k | 0.23% |
| Medical Strategy GmbHas of 30 Nov 2023 | 35.64k | 0.12% |
| SSgA Funds Management, Inc.as of 04 Apr 2024 | 14.64k | 0.05% |
| NOVACAP Asset Management SAas of 31 Mar 2020 | 4.26k | 0.02% |
| Advisory Invest GmbHas of 31 May 2023 | 1.50k | 0.01% |
| Sectoral Asset Management, Inc.as of 31 Jul 2018 | 1.00k | 0.00% |
| Financi�re Arbevel SAas of 30 Dec 2022 | 0.00 | 0.00% |
| Deka Investment GmbHas of 30 Nov 2023 | 0.00 | 0.00% |
More ▼
Data from 29 Oct 2021 - 27 Mar 2024Source: FactSet Research Systems Inc.
